Seropositivity for Helicobacter pylori and hepatobiliary cancers in the PLCO study

[1]  D. Albanes,et al.  Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study , 2014, Hepatology.

[2]  M. Pawlita,et al.  Helicobacter pylori Multiplex Serology , 2009, Helicobacter.

[3]  H. Brenner,et al.  Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. , 2009, Cancer research.

[4]  H. Brenner,et al.  Association between chronic atrophic gastritis and serum antibodies to 15 Helicobacter pylori proteins measured by multiplex serology. , 2009, Cancer research.

[5]  F. Mégraud,et al.  Helicobacter species and liver diseases: association or causation? , 2008, The Lancet. Infectious diseases.

[6]  Y. Nakanuma,et al.  Helicobacter Genus DNA Fragments Are Commonly Detectable in Bile from Patients with Extrahepatic Biliary Diseases and Associated with Their Pathogenesis , 2005, Digestive Diseases and Sciences.

[7]  J. Fox,et al.  Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. , 2005, Gastroenterology.

[8]  A. Hofmann.  Helicobacter and cholesterol gallstones: do findings in the mouse apply to man? , 2005, Gastroenterology.

[9]  X. Tian,et al.  Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma , 2004, Journal of Clinical Pathology.

[10]  Y. Huang,et al.  Helicobacter species ribosomal DNA recovered from the liver tissue of chinese patients with primary hepatocellular carcinoma. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  P. Maisonneuve,et al.  Helicobacter pylori and the risk of benign and malignant biliary tract disease , 2002, Cancer.

[12]  J. Sung,et al.  Helicobacter species and hepatobiliary diseases , 2002 .

[13]  J. Gohagan,et al.  Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. , 2000, Controlled clinical trials.

[14]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[15]  F. Mégraud,et al.  Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma , 2000, Cancer.

[16]  Z. Shen,et al.  Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. , 1998, Gastroenterology.

[17]  J. Fox,et al.  Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus , 1996, Infection and immunity.

[18]  F. Dewhirst,et al.  Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice , 1995, Journal of clinical microbiology.

[19]  J. Ward,et al.  Chronic active hepatitis in mice caused by Helicobacter hepaticus. , 1994, The American journal of pathology.

[20]  P C Prorok,et al.  A national cancer institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers , 2010, Cancer.

[21]  Daan Brandenbarg.  The National. , 1892 .